IntrinsiQ is the premier source for US oncology data and analysis. IntrinsiQs market leading software application, IntelliDose®, captures the treatment decisions and details of over 17,000 patients a month, creating an unrivaled database of accurate, detailed and timely information about the medical oncology care process. This database is the foundation of products and services that are designed to uniquely address the business issues and decisions to the pharmaceutical product manager, market researcher and financial analyst.
Our IntelliDose® application automates the clinical practice of oncology from the assignment of therapy to the calculation of chemotherapy doses to the documentation of care. IntelliDose® can improve the practice of medical oncology - and improve the quality of patient care.
More information about IntelliDose »
In the past, the data available on the oncology care process in the U.S. was only a fraction of what exists for most other pharmaceutical market segments. IntrinsiQ has overcome the obstacles to oncology data by using its IntelliDose® clinical software application to electronically harvest oncology care information.
More information about IQ Analytics »